Corporate Information And Statement Of Ifrs Compliance [Abstract]

Sopharma AD - Filing #6218824

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Sopharma AD	—
Domicile of entity	—	Bulgaria	—
Legal form of entity	—	AD	—
Country of incorporation	—	Bulgaria	—
Address of entity's registered office	—	Sofia, 16, Iliensko Shousse St.	—
Principal place of business	—	Bulgaria	—
Description of nature of entity's operations and principal activities	—	complementary activities to the production of pharmaceutical products and	—
Name of parent entity	—	There was no indentified parent company or other controlling party, different from the parent	—
Name of ultimate parent of group	—	There was no identified ultimate parent company or other controlling party, different from the	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	255,949,000 BGN	—	287,569,000 BGN
Current trade receivables	227,832,000 BGN	—	250,707,000 BGN